Correction to: Nature Communications 10.1038/s41467-022-28069-2, published online 24 January 2022.
In this article the author name Rolf F. Schulte was incorrectly written as Rolf S. Schulte. The original article has been corrected.
. 2022 Mar 7;13:1274. doi: 10.1038/s41467-022-28979-1
Author Correction: Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer
Nikita Sushentsev
1, Mary A McLean
1,2, Anne Y Warren
3, Arnold J V Benjamin
1, Cara Brodie
2, Amy Frary
1, Andrew B Gill
1, Julia Jones
2, Joshua D Kaggie
1, Benjamin W Lamb
4,5, Matthew J Locke
1, Jodi L Miller
2, Ian G Mills
6,7,8,9, Andrew N Priest
1, Fraser J L Robb
10, Nimish Shah
4, Rolf F Schulte
11, Martin J Graves
1, Vincent J Gnanapragasam
4,12,13, Kevin M Brindle
2,14, Tristan Barrett
1,✉,#, Ferdia A Gallagher
1,#
Nikita Sushentsev
1Department of Radiology, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK
Find articles by Nikita Sushentsev
Mary A McLean
1Department of Radiology, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK
2Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
Find articles by Mary A McLean
Anne Y Warren
3Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Find articles by Anne Y Warren
Arnold J V Benjamin
1Department of Radiology, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK
Find articles by Arnold J V Benjamin
Cara Brodie
2Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
Find articles by Cara Brodie
Amy Frary
1Department of Radiology, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK
Find articles by Amy Frary
Andrew B Gill
1Department of Radiology, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK
Find articles by Andrew B Gill
Julia Jones
2Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
Find articles by Julia Jones
Joshua D Kaggie
1Department of Radiology, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK
Find articles by Joshua D Kaggie
Benjamin W Lamb
4Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
5School of Allied Health, Anglia Ruskin University, Cambridge, UK
Find articles by Benjamin W Lamb
Matthew J Locke
1Department of Radiology, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK
Find articles by Matthew J Locke
Jodi L Miller
2Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
Find articles by Jodi L Miller
Ian G Mills
6Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, UK
7Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK
8Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway
9Department of Clinical Science, University of Bergen, Bergen, Norway
Find articles by Ian G Mills
Andrew N Priest
1Department of Radiology, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK
Find articles by Andrew N Priest
Nimish Shah
4Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Find articles by Nimish Shah
Martin J Graves
1Department of Radiology, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK
Find articles by Martin J Graves
Vincent J Gnanapragasam
4Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
12Division of Urology, Department of Surgery, University of Cambridge, Cambridge, UK
13Cambridge Urology Translational Research and Clinical Trials Office, Cambridge Biomedical Campus, Addenbrooke’s Hospital, Cambridge, UK
Find articles by Vincent J Gnanapragasam
Kevin M Brindle
2Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
14Department of Biochemistry, University of Cambridge, Cambridge, UK
Find articles by Kevin M Brindle
Tristan Barrett
1Department of Radiology, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK
Find articles by Tristan Barrett
Ferdia A Gallagher
1Department of Radiology, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK
Find articles by Ferdia A Gallagher
1Department of Radiology, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK
2Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
3Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
4Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
5School of Allied Health, Anglia Ruskin University, Cambridge, UK
6Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, UK
7Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK
8Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway
9Department of Clinical Science, University of Bergen, Bergen, Norway
10GE Healthcare, Aurora, OH USA
11GE Healthcare, Munich, Germany
12Division of Urology, Department of Surgery, University of Cambridge, Cambridge, UK
13Cambridge Urology Translational Research and Clinical Trials Office, Cambridge Biomedical Campus, Addenbrooke’s Hospital, Cambridge, UK
14Department of Biochemistry, University of Cambridge, Cambridge, UK
✉
Corresponding author.
#
Contributed equally.
Collection date 2022.
Subject terms: Cancer imaging, Cancer metabolism, Prostate cancer, Prostate
Subject terms: Cancer imaging, Cancer metabolism, Prostate cancer, Prostate
© The Author(s) 2022
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
PMCID: PMC8901739 PMID: 35256616
This corrects the article "Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer", 466.